Effects of ISIS 113715 on Insulin Sensitivity, Glucose, and Lipid Metabolism and Energy Expenditure in Type 2 Diabetics

NCT00330200 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Due to poor enrollment

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: ISIS 113715

Sponsor

Ionis Pharmaceuticals, Inc.